Avapro is usually prescribed once daily; taking it at the same time each day-whether in the morning or evening-helps maintain steady blood levels and improves blood-pressure control.
If a dose is missed, take it as soon as you remember on the same day. Do not take a double dose to make up for the missed one; instead, continue with the regular dosing schedule aligned to your new local time.
Both generic irbesartan and Avapro contain the same active ingredient. Tablet appearance, imprint code, and inactive ingredients may vary by manufacturer, but the therapeutic effect is equivalent when the strength matches (150 mg or 300 mg).
Irbesartan is not a prohibited substance in standard workplace or athletic drug-testing panels. Therefore, Avapro should not cause a positive result in routine tests.
Combining an ARB with an ACE inhibitor can increase the risk of renal dysfunction and hyperkalaemia, especially in patients with existing kidney disease. Such combinations are generally avoided unless closely monitored by a specialist.
Both ARBs and ACE inhibitors lower blood pressure by interfering with the renin-angiotensin system. ARBs, including Avapro, tend to have a lower incidence of cough and angio-oedema compared with ACE inhibitors, which may influence a clinician’s choice based on patient tolerance.
A diet high in potassium (e.g., bananas, orange juice) does not inherently contraindicate Avapro, but patients must have their serum potassium monitored regularly, especially if they have renal impairment or are on other potassium-sparing agents.
Immediate medical attention is needed if you experience swelling of the face or throat, difficulty breathing, severe dizziness, or signs of an irregular heartbeat, as these may indicate angio-oedema, profound hypotension, or hyperkalaemia.
Elderly patients often benefit from the lower starting dose (150 mg) and need regular monitoring of kidney function and electrolytes due to the higher prevalence of comorbidities. Dose adjustments are made based on individual response and tolerability.
Over-the-counter NSAIDs (e.g., ibuprofen, naproxen) can reduce Avapro’s blood-pressure-lowering effect and increase the risk of kidney injury. If occasional use is necessary, take the lowest effective dose for the shortest duration and discuss it with your pharmacist.
Avapro is a brand name medication that contains irbesartan as its active component. Irbesartan belongs to the class of angiotensin II receptor blockers (ARBs) and is used to manage high blood pressure and protect the kidneys in people with certain types of diabetes. In the United Kingdom, Avapro is a prescription-only (POM) product regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Irbesartan selectively blocks the binding of angiotensin II to the AT₁ receptor on blood-vessel smooth muscle and adrenal tissue. By preventing this interaction, the drug reduces vasoconstriction and the release of aldosterone, which together lower systemic vascular resistance and promote sodium-water excretion. The result is a gradual reduction in blood pressure, usually evident within a few weeks of consistent use. Irbesartan is well absorbed after oral administration, with an onset of action within 2 hours and a half-life of approximately 11-15 hours, supporting once-daily dosing.
These indications are endorsed by the UK National Institute for Health and Care Excellence (NICE) and are reflected in the product’s Summary of Product Characteristics (SmPC).
Who should use Avapro?
Absolute contraindications
Relative contraindications / precautions
This article provides educational information about Avapro and is not a substitute for professional medical advice. Treatment decisions, including the choice to use this medication for any indication, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
